Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.54 USD | -2.45% | -1.21% | +22.17% |
Apr. 19 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
Apr. 01 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.17% | 2.22B | |
+4.86% | 2,894B | |
+1.35% | 80.94B | |
+0.83% | 75.01B | |
-16.29% | 52.08B | |
+27.02% | 48.93B | |
-27.70% | 44.85B | |
+17.86% | 40.49B | |
+54.20% | 36.29B | |
-10.78% | 24.36B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Transcript : Cellebrite DI Ltd., Q4 2023 Earnings Call, Feb 15, 2024